X

Drug Profile

Research programme: melanin-concentrating hormone receptor 1 antagonists - Abbott

Alternative Names: A 798

Latest Information Update: 01 Feb 2013

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Abbott Laboratories
Class Small molecules
Mechanism of Action MCHR1 protein inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued Obesity

Most Recent Events

02 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
29 Sep 2006 Discontinued - Preclinical for Obesity in USA (unspecified route)
10 Dec 2004 Preclinical trials in Obesity in USA (unspecified route)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com